"With time, I started to notice my symptoms improving. Now I'm able to go about my day with less symptoms getting in my way."
May offer lasting relief of symptoms in as little as 2 weeks for some patients with continued twice-daily use
Specifically targets a source of inflammation that can cause dry eye disease
Approximately 1,500,000 patients‡ have been prescribed Xiidra
Commercially insured patients may pay as little as $0 for prescriptions of Xiidra
‡Calculation completed by IQVIA based on a March 2014 to February 2020 study period.
THE RELIEF YOUR
DRY EYES MAY NEED
Xiidra has been studied in more than 1000 patients with dry eye in 4 separate 12-week clinical studies. In some patients at 12 weeks, Xiidra was shown to reduce symptoms of eye dryness in all 4 studies and Inferior fluorescein Corneal Staining Score in 3 of 4 studies.
Xiidra may not work for everyone, but we hope it works for you. Ask your eye doctor if Xiidra is right for you.
Get the full scoop about how Xiidra performed in clinical trials—plus additional Indication and Important Safety Information—by reading the Full Prescribing Information for Xiidra.
§Xiidra reduced symptoms of eye dryness at 2 weeks in 2 out of 4 studies, with improvements observed at 6 and 12 weeks in all 4 studies.
HOW TO USE XIIDRA
Instill 1 drop of Xiidra twice daily, approximately 12 hours apart, into each eye using the single-use container. Discard the single-use container immediately after using in each eye.